Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the recipient of a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 727,270 shares, a decrease of 19.9% from the October 14th total of 907,887 shares. Approximately 4.3% of the shares of the company are short sold. Based on an average trading volume of 322,023 shares, the short-interest ratio is presently 2.3 days.

Ekso Bionics Holdings (NASDAQ:EKSO) opened at 4.15 on Friday. The company has a 50-day moving average of $4.89 and a 200 day moving average of $5.09. Ekso Bionics Holdings has a 12-month low of $3.45 and a 12-month high of $9.80. The company’s market capitalization is $68.19 million.

A number of hedge funds and other institutional investors have recently modified their holdings of the company. KCG Holdings Inc. purchased a new position in shares of Ekso Bionics Holdings during the third quarter valued at about $186,000. Spark Investment Management LLC purchased a new position in shares of Ekso Bionics Holdings during the third quarter valued at about $185,000. Finally, Northern Trust Corp purchased a new position in shares of Ekso Bionics Holdings during the third quarter valued at about $130,000.

A number of research analysts have recently weighed in on EKSO shares. Zacks Investment Research downgraded shares of Ekso Bionics Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 2nd. Rodman & Renshaw reissued a “buy” rating on shares of Ekso Bionics Holdings in a research report on Sunday, July 31st. B. Riley started coverage on shares of Ekso Bionics Holdings in a report on Wednesday, September 21st. They issued a “buy” rating and a $8.00 price objective for the company. Finally, SunTrust Banks Inc. started coverage on shares of Ekso Bionics Holdings in a report on Thursday, October 13th. They issued a “buy” rating and a $8.00 price objective for the company.

5 Day Chart for NASDAQ:EKSO

Receive News & Stock Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related stocks with our FREE daily email newsletter.